VICTORIA, April 12 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation , an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines available for patients living with less common diseases, announced today that the company will release financial and business results for the first quarter ending March 31, 2006 on Wednesday, April 26th. The Company will hold a conference call and webcast beginning at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these results.
The webcast and conference call will be available to all interested parties. To access the live call or the archive via the Internet, please click on Webcasts and Events under the Investors section of the Company's website at www.aspreva.com. Alternatively, please dial 1-866-510-0710 (North America) or 1-617-597-5378 (International) and enter the pass code 31880614 to participate in the call. The call will be available for replay until Wednesday, May 3rd, by calling 1-888-286-8010 (North America) or 1-617-801-6888 (International) and entering the pass code 76284010. The webcast replay will be available on Aspreva's website until the Company's second quarter 2006 conference call.
About Aspreva Pharmaceuticals
Aspreva is an emerging pharmaceutical company focused on identifying, developing and, upon regulatory approval, commercializing new indications for approved drugs and drug candidates for patients living with less common diseases. Aspreva's "Indication Partnering" strategy allows its partners to maintain core brand focus while extending the benefits of their medicines to a broader patient population.
For further information please contact: Sage Baker Executive Director, Corporate & Investor Affairs Aspreva Pharmaceuticals 250-744-2488 sbaker@aspreva.com
Aspreva PharmaceuticalsCONTACT: Sage Baker, Executive Director, Corporate & Investor Affairs,Aspreva Pharmaceuticals, (250) 744-2488, sbaker@aspreva.com
